RxDoctor Payments Data

Richard Leland, MD

Family Medicine · Greenville, SCNPI 1184659880

Payments from drug & device makers

$18,636in general payments, 2019–2025

Across 975 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novo Nordisk$2K
  • Amgen$2K
  • Lilly USA, LLC$1K
  • AstraZeneca$1K
  • Johnson & Johnson$961
  • plus $9K from 54 others

What the payments were for

  • Consulting fees$1751%
  • Speaking & faculty fees$2321%
  • Food & beverage$18,15497%
  • Education$750%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)200$3,364
Novo Nordisk121$1,689
Amgen(2 entities)54$1,621
Lilly USA, LLC83$1,150
AstraZeneca46$1,081
Johnson & Johnson30$961
Pfizer55$718
Bayer36$610
Astellas Pharma US Inc22$465
GSK30$449
Abbott23$442
Dexcom, Inc.18$416
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$395
Esperion Therapeutics, Inc.15$381
Lundbeck LLC19$371
Exact Sciences17$362
Sanofi-aventis U.S. LLC18$348
Phathom Pharmaceuticals, Inc.12$338
Amarin Pharma, Inc.11$285
Boehringer Ingelheim16$240
Axsome Therapeutics, Inc.7$231
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)11$215
Novartis13$215
Takeda Pharmaceuticals U.S.A., Inc.12$212
Ironshore Pharmaceuticals Inc.3$204
Daiichi Sankyo Inc.10$190
Medtronic(2 entities)3$144
Insmed, Inc.2$122
Mayne Pharma Commercial LLC1$121
Sanofi1$110
Merck7$106
Kowa Pharmaceuticals America, Inc.5$88
Eisai Inc.4$81
Scilex Pharmaceuticals Inc.4$79
Paratek Pharmaceuticals, Inc.4$74
Idorsia Pharmaceuticals US Inc4$62
E.r. Squibb & Sons, L.L.C.4$56
Gilead4$51
Corium, LLC3$50
Shield Therapeutics Inc3$49
Hikma Pharmaceuticals USA3$41
VBI Vaccine (delaware) Inc.2$39
Boston Scientific3$37
Arbor Pharmaceuticals, Inc.2$33
Biohaven Pharmaceutical Holding Company Ltd.2$33
Antares Pharma, Inc.2$30
Sanofi Pasteur Inc.2$28
Ultragenyx Pharmaceutical Inc.1$21
Clarus Therapeutics Inc.2$21
Azurity Pharmaceuticals, Inc.1$19
Upsher-smith Laboratories LLC1$17
Tris Pharma Inc1$17
Nevro Corp.1$17
Supernus Pharmaceuticals, Inc.1$16
Inspire Medical Systems, Inc.1$15
Sunovion Pharmaceuticals Inc.1$14
Eyevance Pharmaceuticals LLC1$14
Adlon Therapeutics L.p.1$14
Almatica Pharma LLC1$14
Currax Pharmaceuticals LLC1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,636 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$103,975
Medicare patients
257
Services billed
2,035

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin37$62,347
XareltoRivaroxaban24$33,735
RybelsusSemaglutide11$27,497
EliquisApixaban17$27,112
OzempicSemaglutide16$24,762
JanuviaSitagliptin Phosphate13$20,847
MyrbetriqMirabegron11$13,760
InvokanaCanagliflozin16$11,678
Levothyroxine Sodium243$2,488
Atorvastatin Calcium248$2,424
Omeprazole180$1,815
Montelukast Sodium147$1,727
Fesoterodine Fumarate ErFesoterodine Fumarate11$1,630
Pantoprazole Sodium83$1,415
Ezetimibe68$1,308

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$240$62,34737 claims
Novo NordiskRybelsus, Ozempic$1,689$52,26027 claims
Johnson & JohnsonXarelto, Invokana$961$45,41340 claims
PfizerEliquis$718$27,11217 claims
MerckJanuvia$106$20,84713 claims
Astellas Pharma US IncMyrbetriq$465$13,76011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →